scholarly journals Perceptions of older men using a mobile health application to monitor lower urinary tract symptoms and tamsulosin side effects: mixed-methods study (Preprint)

10.2196/30767 ◽  
2021 ◽  
Author(s):  
Elizabeth Y Wang ◽  
Benjamin N Breyer ◽  
Austin W Lee ◽  
Natalie Rios ◽  
Akinyemi Oni-Orisan ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Side Effects ◽  
Mobile Health ◽  
Lower Urinary Tract ◽  
Older Men ◽  
Mixed Methods Study ◽  
Mobile Health Application ◽  
Urinary Tract Symptoms ◽  
Health Application ◽  
Lower Urinary

Perceptions of older men using a mobile health application to monitor lower urinary tract symptoms and tamsulosin side effects: mixed-methods study (Preprint)

2021 ◽  
Author(s):  
Elizabeth Y Wang ◽  
Benjamin N Breyer ◽  
Austin W Lee ◽  
Natalie Rios ◽  
Akinyemi Oni-Orisan ◽  
...  
Keyword(s):  
Side Effects ◽  
Mobile Health ◽  
Mobile Application ◽  
Older Men ◽  
Mobile Health Application ◽  
Urinary Tract Symptoms ◽  
Medication Side ◽  
Mobile Health Applications ◽  
Health Application ◽  
Health Applications

BACKGROUND Mobile health applications may provide an efficient way for patients with lower urinary tract symptoms (LUTS) to log and communicate symptoms and medication side effects with their clinicians. OBJECTIVE To explore the perceptions of older men with LUTS after using a mobile health application to track their symptoms and tamsulosin side effects. METHODS Structured phone interviews were conducted after a 2-week study piloting the daily use of a mobile application to track severity of patient-selected LUTS and tamsulosin side effects. Quantitative and qualitative data were considered. RESULTS Nineteen (100%) pilot study participants completed the post-study interviews. Most men (68%) reported that the daily questionnaires were the right length, with 32% reporting that the questionnaires were too short. Men with more severe symptoms were less likely to report changes in perception of health or changes in self-management; 47% of men reported improved awareness of symptoms and 5% of men adjusted fluid intake based on the questionnaire. All men were willing to share application data with their clinicians. Thematic analysis of qualitative data yielded 8 themes: 1) orientation (setting up app, format, symptom selection, side effect selection), 2) triggers (routine/habit, symptom timing), 3) daily questionnaire (reporting symptoms, reporting side effects, tailoring), 4) technology literacy, 5) perceptions (awareness, causation/relevance, data quality, convenience, usefulness, other apps), 6) self-management, 7) clinician engagement (communication, efficiency), and 8) improvement (reference materials, flexibility, language, management recommendations, optimize clinician engagement). CONCLUSIONS We assessed the perceptions of men using a mobile health application to monitor and improve management of LUTS and medication side effects. LUTS management may be further optimized by tailoring the mobile application experience to meet patients’ individual needs, such as tracking a greater number of symptoms and integrating the application with clinicians’ visits. Mobile health applications are likely a scalable modality to monitor symptoms and improve care of older men with LUTS. Further study is required to determine the best ways to tailor the mobile application and to communicate data to clinicians or incorporate data into the electronical medical record meaningfully.

scholarly journals Co‐Occurrence of Lower Urinary Tract Symptoms and Frailty among Community‐Dwelling Older Men

2020 ◽  
Vol 68 (12) ◽  
pp. 2805-2813
Author(s):  
Scott R. Bauer ◽  
Rebecca Scherzer ◽  
Anne M. Suskind ◽  
Peggy Cawthon ◽  
Kristine E. Ensrud ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Older Men ◽  
Community Dwelling ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

scholarly journals Drugs used in prostatic enlargement and lower urinary tract symptoms: unseen and overlooked effects on sexual health

2019 ◽  
Vol 9 (3) ◽  
pp. 240-247
Author(s):  
SM Ashrafuzzaman ◽  
Muhammad Abdur Rahim ◽  
Zafar Ahmed Latif
Keyword(s):  
Urinary Tract ◽  
Side Effects ◽  
Lower Urinary Tract Symptoms ◽  
Side Effect ◽  
Lower Urinary Tract ◽  
Reductase Inhibitors ◽  
Adrenergic Antagonist ◽  
Urinary Tract Symptoms ◽  
Prostatic Enlargement ◽  
Lower Urinary

Benign prostatic hyperplasia (BPH) is one of the most common genitourinary complications in men over 50 years of age and typically presents with lower urinary tract symptoms (LUTS) and may need medical and occasionally surgical interventions. Few of them may only need advice on behavioral modification like less water intake after sunset, avoid tea, coffee after evening, avoid alcohol and less use of diuretics. The symptoms related to BPH or LUTS without any prostatic enlargement are incomplete voiding, frequency, intermittency, urgency, weak stream, straining and nocturia. For most patients with mild to moderate symptoms of BPH [International Prostate Symptom Score (IPSS) <8 or 8-19 respectively] monotherapy with an á-1-adrenergic antagonist remains initial treatment. The choice of specific á-adrenergic antagonist agent is generally based on cost and side effect profile. Other classes of medications include 5á-reductase inhibitors and phosphodiesterase (PDE) 5 inhibitors. In men who have mild to moderate symptoms of BPH and concomitant erectile dysfunction (ED), PDE-5 inhibitors are reasonable alternative. Now a days á-1-adrenoceptor blockers and 5á-reductase inhibitors are often combined to give a synergistic effect. A review of the current literature identified several adverse sexual side effects, including ED, decreased libido, orgasmic disorders and ejaculatory disorders. It is important to know the extent of these side effects, as the clinician and patient will need to decide the cost of improved voiding symptoms. The prime adverse effect is ejaculatory disorders including the absence of ejaculation. Clinical consideration for BPH/LUTS should include the elements of male sexual function, patient’s age and the characteristics and comprehensive effects of each group of drugs. Methodological bias in clinical studies, such as the subjective evaluation of the sexual side effect makes it difficult to determine the ideal drug for treatment. Men without ED or irritant symptoms who desire medical therapy but cannot tolerate á-1-adrenergic antagonists and do not have predominately irritant symptoms or concomitant ED, treatment with a 5á-reductase inhibitor is a reasonable. Treatment for 6 to 12 months is generally needed before prostate size is sufficiently reduced to improve symptoms. Symptoms are usually reversible, so drugs may need to be continued for long time or indefinitely under supervision of specialist. Birdem Med J 2019; 9(3): 240-247

SERUM ANDROGENS AND RISK OF LOWER URINARY TRACT SYMPTOMS IN COMMUNITY DWELLING OLDER MEN

2009 ◽  
Vol 181 (4S) ◽  
pp. 526-526
Author(s):  
J. Kellogg Parsons ◽  
Michael D Trifiro ◽  
Jaclyn Bergstrom ◽  
Kerrin Palazzi-Churas ◽  
Elizabeth Barrett-Connor
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Older Men ◽  
Community Dwelling ◽  
Urinary Tract Symptoms ◽  
Serum Androgens ◽  
Lower Urinary

scholarly journals Reasons for Seeking Clinical Care for Lower Urinary Tract Symptoms: A Mixed Methods Study

2018 ◽  
Vol 199 (2) ◽  
pp. 528-535 ◽  
Author(s):  
James W. Griffith ◽  
Emily E. Messersmith ◽  
Brenda W. Gillespie ◽  
Jonathan B. Wiseman ◽  
Kathryn E. Flynn ◽  
...  
Keyword(s):  
Mixed Methods ◽  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Clinical Care ◽  
Mixed Methods Study ◽  
Urinary Tract Symptoms ◽  
Lower Urinary
Sign in / Sign up

Export Citation Format

Share Document